nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—SLCO1B1—Quinidine—malaria	0.164	0.234	CbGbCtD
Valsartan—CYP2C9—Sulfadiazine—malaria	0.107	0.153	CbGbCtD
Valsartan—CYP2C9—Pyrimethamine—malaria	0.107	0.153	CbGbCtD
Valsartan—CYP2C9—Artemether—malaria	0.0911	0.13	CbGbCtD
Valsartan—CYP2C9—Proguanil—malaria	0.0857	0.122	CbGbCtD
Valsartan—CYP2C9—Quinine—malaria	0.0552	0.0787	CbGbCtD
Valsartan—CYP2C9—Quinidine—malaria	0.0485	0.0692	CbGbCtD
Valsartan—CYP2C9—Dapsone—malaria	0.0418	0.0597	CbGbCtD
Valsartan—AGTR1—endothelium—malaria	0.00719	0.125	CbGeAlD
Valsartan—AGTR1—blood plasma—malaria	0.00638	0.111	CbGeAlD
Valsartan—SLCO1B1—blood plasma—malaria	0.00608	0.106	CbGeAlD
Valsartan—AGTR1—hematopoietic system—malaria	0.00353	0.0612	CbGeAlD
Valsartan—SLCO1B1—hematopoietic system—malaria	0.00336	0.0584	CbGeAlD
Valsartan—CYP2C9—blood plasma—malaria	0.00307	0.0533	CbGeAlD
Valsartan—SLCO1B3—liver—malaria	0.00301	0.0523	CbGeAlD
Valsartan—AGTR1—kidney—malaria	0.00289	0.0502	CbGeAlD
Valsartan—SLCO1B1—kidney—malaria	0.00276	0.0479	CbGeAlD
Valsartan—SLCO1B1—digestive system—malaria	0.00234	0.0406	CbGeAlD
Valsartan—AGTR1—blood—malaria	0.00234	0.0406	CbGeAlD
Valsartan—SLCO1B1—blood—malaria	0.00223	0.0387	CbGeAlD
Valsartan—AGTR1—liver—malaria	0.00183	0.0317	CbGeAlD
Valsartan—SLCO1B1—liver—malaria	0.00174	0.0303	CbGeAlD
Valsartan—CYP2C9—hematopoietic system—malaria	0.0017	0.0295	CbGeAlD
Valsartan—AGTR1—brain—malaria	0.00145	0.0252	CbGeAlD
Valsartan—ALB—liver—malaria	0.00141	0.0245	CbGeAlD
Valsartan—CYP2C9—digestive system—malaria	0.00118	0.0205	CbGeAlD
Valsartan—CYP2C9—blood—malaria	0.00113	0.0195	CbGeAlD
Valsartan—ALB—brain—malaria	0.00112	0.0194	CbGeAlD
Valsartan—ALB—Scavenging of heme from plasma—HBB—malaria	0.00105	0.0697	CbGpPWpGaD
Valsartan—Photosensitivity reaction—Quinidine—malaria	0.000993	0.00439	CcSEcCtD
Valsartan—ALB—Scavenging of heme from plasma—HP—malaria	0.000965	0.0644	CbGpPWpGaD
Valsartan—Sinusitis—Dapsone—malaria	0.000959	0.00424	CcSEcCtD
Valsartan—Renal failure—Quinine—malaria	0.000953	0.00422	CcSEcCtD
Valsartan—Renal failure—Quinidine—malaria	0.000953	0.00422	CcSEcCtD
Valsartan—Epistaxis—Clindamycin—malaria	0.000933	0.00412	CcSEcCtD
Valsartan—Vertigo—Sulfadiazine—malaria	0.000932	0.00412	CcSEcCtD
Valsartan—Neutropenia—Quinidine barbiturate—malaria	0.000918	0.00406	CcSEcCtD
Valsartan—Pharyngitis—Dapsone—malaria	0.000911	0.00403	CcSEcCtD
Valsartan—Photosensitivity reaction—Quinidine barbiturate—malaria	0.000896	0.00396	CcSEcCtD
Valsartan—Arthralgia—Sulfadiazine—malaria	0.000883	0.00391	CcSEcCtD
Valsartan—CYP2C9—liver—malaria	0.00088	0.0153	CbGeAlD
Valsartan—Haemoglobin—Quinidine—malaria	0.000875	0.00387	CcSEcCtD
Valsartan—Haemoglobin—Quinine—malaria	0.000875	0.00387	CcSEcCtD
Valsartan—Infestation NOS—Pentoxifylline—malaria	0.000874	0.00386	CcSEcCtD
Valsartan—Infestation—Pentoxifylline—malaria	0.000874	0.00386	CcSEcCtD
Valsartan—Diarrhoea—Proguanil—malaria	0.000873	0.00386	CcSEcCtD
Valsartan—Hepatitis—Quinine—malaria	0.000871	0.00385	CcSEcCtD
Valsartan—Haemorrhage—Quinine—malaria	0.000871	0.00385	CcSEcCtD
Valsartan—Hepatitis—Quinidine—malaria	0.000871	0.00385	CcSEcCtD
Valsartan—Haemorrhage—Quinidine—malaria	0.000871	0.00385	CcSEcCtD
Valsartan—Renal failure—Quinidine barbiturate—malaria	0.000861	0.0038	CcSEcCtD
Valsartan—Urinary tract disorder—Quinidine—malaria	0.00086	0.0038	CcSEcCtD
Valsartan—Urinary tract disorder—Quinine—malaria	0.00086	0.0038	CcSEcCtD
Valsartan—Urethral disorder—Quinidine—malaria	0.000854	0.00377	CcSEcCtD
Valsartan—Urethral disorder—Quinine—malaria	0.000854	0.00377	CcSEcCtD
Valsartan—Anaphylactic shock—Sulfadiazine—malaria	0.000847	0.00374	CcSEcCtD
Valsartan—Thrombocytopenia—Sulfadiazine—malaria	0.000829	0.00367	CcSEcCtD
Valsartan—Epistaxis—Pentoxifylline—malaria	0.000824	0.00364	CcSEcCtD
Valsartan—Vomiting—Proguanil—malaria	0.000811	0.00359	CcSEcCtD
Valsartan—Cardiac disorder—Quinidine—malaria	0.000808	0.00357	CcSEcCtD
Valsartan—Cardiac disorder—Quinine—malaria	0.000808	0.00357	CcSEcCtD
Valsartan—Anorexia—Sulfadiazine—malaria	0.000807	0.00357	CcSEcCtD
Valsartan—Rash—Proguanil—malaria	0.000804	0.00356	CcSEcCtD
Valsartan—Dermatitis—Proguanil—malaria	0.000804	0.00355	CcSEcCtD
Valsartan—Headache—Proguanil—malaria	0.000799	0.00353	CcSEcCtD
Valsartan—Haemoglobin—Quinidine barbiturate—malaria	0.00079	0.00349	CcSEcCtD
Valsartan—Haemoglobin—Pentoxifylline—malaria	0.000788	0.00349	CcSEcCtD
Valsartan—Immune system disorder—Quinine—malaria	0.000787	0.00348	CcSEcCtD
Valsartan—Immune system disorder—Quinidine—malaria	0.000787	0.00348	CcSEcCtD
Valsartan—Haemorrhage—Quinidine barbiturate—malaria	0.000786	0.00347	CcSEcCtD
Valsartan—Hepatitis—Quinidine barbiturate—malaria	0.000786	0.00347	CcSEcCtD
Valsartan—Mediastinal disorder—Quinidine—malaria	0.000785	0.00347	CcSEcCtD
Valsartan—Mediastinal disorder—Quinine—malaria	0.000785	0.00347	CcSEcCtD
Valsartan—Haemorrhage—Pentoxifylline—malaria	0.000784	0.00347	CcSEcCtD
Valsartan—Hepatitis—Pentoxifylline—malaria	0.000784	0.00347	CcSEcCtD
Valsartan—Urinary tract disorder—Quinidine barbiturate—malaria	0.000776	0.00343	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000772	0.00341	CcSEcCtD
Valsartan—Urethral disorder—Quinidine barbiturate—malaria	0.00077	0.00341	CcSEcCtD
Valsartan—Insomnia—Sulfadiazine—malaria	0.000766	0.00339	CcSEcCtD
Valsartan—Mental disorder—Quinine—malaria	0.000763	0.00337	CcSEcCtD
Valsartan—Mental disorder—Quinidine—malaria	0.000763	0.00337	CcSEcCtD
Valsartan—Flatulence—Clindamycin—malaria	0.000761	0.00337	CcSEcCtD
Valsartan—Malnutrition—Quinidine—malaria	0.000758	0.00335	CcSEcCtD
Valsartan—Malnutrition—Quinine—malaria	0.000758	0.00335	CcSEcCtD
Valsartan—Nausea—Proguanil—malaria	0.000758	0.00335	CcSEcCtD
Valsartan—Dysgeusia—Clindamycin—malaria	0.000757	0.00335	CcSEcCtD
Valsartan—Vision blurred—Dapsone—malaria	0.000753	0.00333	CcSEcCtD
Valsartan—Back pain—Clindamycin—malaria	0.000747	0.0033	CcSEcCtD
Valsartan—Muscle spasms—Clindamycin—malaria	0.000743	0.00328	CcSEcCtD
Valsartan—Decreased appetite—Sulfadiazine—malaria	0.000736	0.00326	CcSEcCtD
Valsartan—Gastrointestinal disorder—Sulfadiazine—malaria	0.000731	0.00323	CcSEcCtD
Valsartan—AGTR1—Peptide GPCRs—ACKR1—malaria	0.00073	0.0487	CbGpPWpGaD
Valsartan—Cardiac disorder—Quinidine barbiturate—malaria	0.000729	0.00322	CcSEcCtD
Valsartan—Vertigo—Dapsone—malaria	0.000718	0.00317	CcSEcCtD
Valsartan—Vision blurred—Quinidine—malaria	0.000714	0.00316	CcSEcCtD
Valsartan—Vision blurred—Quinine—malaria	0.000714	0.00316	CcSEcCtD
Valsartan—Immune system disorder—Quinidine barbiturate—malaria	0.00071	0.00314	CcSEcCtD
Valsartan—Immune system disorder—Pentoxifylline—malaria	0.000709	0.00313	CcSEcCtD
Valsartan—Mediastinal disorder—Quinidine barbiturate—malaria	0.000708	0.00313	CcSEcCtD
Valsartan—Cough—Dapsone—malaria	0.000697	0.00308	CcSEcCtD
Valsartan—Vertigo—Clindamycin—malaria	0.000694	0.00307	CcSEcCtD
Valsartan—Angioedema—Quinidine—malaria	0.000693	0.00306	CcSEcCtD
Valsartan—Angioedema—Quinine—malaria	0.000693	0.00306	CcSEcCtD
Valsartan—Gastrointestinal pain—Sulfadiazine—malaria	0.000692	0.00306	CcSEcCtD
Valsartan—Mental disorder—Quinidine barbiturate—malaria	0.000688	0.00304	CcSEcCtD
Valsartan—Malnutrition—Quinidine barbiturate—malaria	0.000684	0.00302	CcSEcCtD
Valsartan—Vertigo—Quinine—malaria	0.000681	0.00301	CcSEcCtD
Valsartan—Vertigo—Quinidine—malaria	0.000681	0.00301	CcSEcCtD
Valsartan—Syncope—Quinidine—malaria	0.00068	0.00301	CcSEcCtD
Valsartan—Syncope—Quinine—malaria	0.00068	0.00301	CcSEcCtD
Valsartan—Flatulence—Pentoxifylline—malaria	0.000673	0.00298	CcSEcCtD
Valsartan—Urticaria—Sulfadiazine—malaria	0.000673	0.00297	CcSEcCtD
Valsartan—Palpitations—Quinidine—malaria	0.00067	0.00296	CcSEcCtD
Valsartan—Palpitations—Quinine—malaria	0.00067	0.00296	CcSEcCtD
Valsartan—Abdominal pain—Sulfadiazine—malaria	0.000669	0.00296	CcSEcCtD
Valsartan—Dysgeusia—Pentoxifylline—malaria	0.000669	0.00296	CcSEcCtD
Valsartan—Loss of consciousness—Quinidine—malaria	0.000666	0.00295	CcSEcCtD
Valsartan—Loss of consciousness—Quinine—malaria	0.000666	0.00295	CcSEcCtD
Valsartan—Back pain—Pentoxifylline—malaria	0.000661	0.00292	CcSEcCtD
Valsartan—Muscle spasms—Pentoxifylline—malaria	0.000657	0.0029	CcSEcCtD
Valsartan—Myalgia—Quinidine—malaria	0.000645	0.00285	CcSEcCtD
Valsartan—Chest pain—Quinine—malaria	0.000645	0.00285	CcSEcCtD
Valsartan—Myalgia—Quinine—malaria	0.000645	0.00285	CcSEcCtD
Valsartan—Chest pain—Quinidine—malaria	0.000645	0.00285	CcSEcCtD
Valsartan—Vision blurred—Quinidine barbiturate—malaria	0.000645	0.00285	CcSEcCtD
Valsartan—Vision blurred—Pentoxifylline—malaria	0.000644	0.00285	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000641	0.00283	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000641	0.00283	CcSEcCtD
Valsartan—Anaphylactic shock—Clindamycin—malaria	0.000631	0.00279	CcSEcCtD
Valsartan—Angioedema—Quinidine barbiturate—malaria	0.000625	0.00276	CcSEcCtD
Valsartan—Angioedema—Pentoxifylline—malaria	0.000624	0.00276	CcSEcCtD
Valsartan—Hypersensitivity—Sulfadiazine—malaria	0.000624	0.00276	CcSEcCtD
Valsartan—Oedema—Quinidine—malaria	0.000619	0.00274	CcSEcCtD
Valsartan—Oedema—Quinine—malaria	0.000619	0.00274	CcSEcCtD
Valsartan—Thrombocytopenia—Clindamycin—malaria	0.000617	0.00273	CcSEcCtD
Valsartan—Vertigo—Quinidine barbiturate—malaria	0.000615	0.00272	CcSEcCtD
Valsartan—Syncope—Quinidine barbiturate—malaria	0.000613	0.00271	CcSEcCtD
Valsartan—Shock—Quinidine—malaria	0.000609	0.00269	CcSEcCtD
Valsartan—Shock—Quinine—malaria	0.000609	0.00269	CcSEcCtD
Valsartan—Nervous system disorder—Quinine—malaria	0.000607	0.00268	CcSEcCtD
Valsartan—Nervous system disorder—Quinidine—malaria	0.000607	0.00268	CcSEcCtD
Valsartan—Thrombocytopenia—Quinidine—malaria	0.000606	0.00268	CcSEcCtD
Valsartan—Thrombocytopenia—Quinine—malaria	0.000606	0.00268	CcSEcCtD
Valsartan—Palpitations—Quinidine barbiturate—malaria	0.000605	0.00267	CcSEcCtD
Valsartan—Palpitations—Pentoxifylline—malaria	0.000603	0.00267	CcSEcCtD
Valsartan—Loss of consciousness—Quinidine barbiturate—malaria	0.000601	0.00266	CcSEcCtD
Valsartan—Skin disorder—Quinine—malaria	0.000601	0.00266	CcSEcCtD
Valsartan—Skin disorder—Quinidine—malaria	0.000601	0.00266	CcSEcCtD
Valsartan—Pruritus—Sulfadiazine—malaria	0.000599	0.00265	CcSEcCtD
Valsartan—Anorexia—Quinine—malaria	0.00059	0.00261	CcSEcCtD
Valsartan—Anorexia—Quinidine—malaria	0.00059	0.00261	CcSEcCtD
Valsartan—Insomnia—Dapsone—malaria	0.00059	0.00261	CcSEcCtD
Valsartan—Hypotension—Clindamycin—malaria	0.000589	0.00261	CcSEcCtD
Valsartan—Myalgia—Quinidine barbiturate—malaria	0.000582	0.00258	CcSEcCtD
Valsartan—Chest pain—Quinidine barbiturate—malaria	0.000582	0.00258	CcSEcCtD
Valsartan—Arthralgia—Quinidine barbiturate—malaria	0.000582	0.00258	CcSEcCtD
Valsartan—Chest pain—Pentoxifylline—malaria	0.000581	0.00257	CcSEcCtD
Valsartan—Myalgia—Pentoxifylline—malaria	0.000581	0.00257	CcSEcCtD
Valsartan—Anxiety—Quinidine barbiturate—malaria	0.00058	0.00257	CcSEcCtD
Valsartan—Diarrhoea—Sulfadiazine—malaria	0.000579	0.00256	CcSEcCtD
Valsartan—Anxiety—Pentoxifylline—malaria	0.000579	0.00256	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000578	0.00256	CcSEcCtD
Valsartan—Hypotension—Quinidine—malaria	0.000578	0.00256	CcSEcCtD
Valsartan—Hypotension—Quinine—malaria	0.000578	0.00256	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000577	0.00255	CcSEcCtD
Valsartan—Dry mouth—Pentoxifylline—malaria	0.000569	0.00251	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Quinine—malaria	0.000564	0.00249	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Quinidine—malaria	0.000564	0.00249	CcSEcCtD
Valsartan—Dyspnoea—Clindamycin—malaria	0.000562	0.00249	CcSEcCtD
Valsartan—Oedema—Quinidine barbiturate—malaria	0.000558	0.00247	CcSEcCtD
Valsartan—Anaphylactic shock—Pentoxifylline—malaria	0.000557	0.00246	CcSEcCtD
Valsartan—Oedema—Pentoxifylline—malaria	0.000557	0.00246	CcSEcCtD
Valsartan—Dyspepsia—Clindamycin—malaria	0.000555	0.00245	CcSEcCtD
Valsartan—Infection—Pentoxifylline—malaria	0.000554	0.00245	CcSEcCtD
Valsartan—Dyspnoea—Quinidine—malaria	0.000552	0.00244	CcSEcCtD
Valsartan—Dyspnoea—Quinine—malaria	0.000552	0.00244	CcSEcCtD
Valsartan—Shock—Quinidine barbiturate—malaria	0.000549	0.00243	CcSEcCtD
Valsartan—Shock—Pentoxifylline—malaria	0.000548	0.00242	CcSEcCtD
Valsartan—Nervous system disorder—Quinidine barbiturate—malaria	0.000548	0.00242	CcSEcCtD
Valsartan—Thrombocytopenia—Quinidine barbiturate—malaria	0.000547	0.00242	CcSEcCtD
Valsartan—Thrombocytopenia—Pentoxifylline—malaria	0.000546	0.00241	CcSEcCtD
Valsartan—Gastrointestinal disorder—Clindamycin—malaria	0.000544	0.00241	CcSEcCtD
Valsartan—Fatigue—Clindamycin—malaria	0.000544	0.0024	CcSEcCtD
Valsartan—Skin disorder—Quinidine barbiturate—malaria	0.000542	0.0024	CcSEcCtD
Valsartan—Skin disorder—Pentoxifylline—malaria	0.000541	0.00239	CcSEcCtD
Valsartan—Constipation—Clindamycin—malaria	0.000539	0.00238	CcSEcCtD
Valsartan—Vomiting—Sulfadiazine—malaria	0.000538	0.00238	CcSEcCtD
Valsartan—Decreased appetite—Quinidine—malaria	0.000538	0.00238	CcSEcCtD
Valsartan—Decreased appetite—Quinine—malaria	0.000538	0.00238	CcSEcCtD
Valsartan—Gastrointestinal disorder—Quinine—malaria	0.000534	0.00236	CcSEcCtD
Valsartan—Gastrointestinal disorder—Quinidine—malaria	0.000534	0.00236	CcSEcCtD
Valsartan—Rash—Sulfadiazine—malaria	0.000534	0.00236	CcSEcCtD
Valsartan—Dermatitis—Sulfadiazine—malaria	0.000533	0.00236	CcSEcCtD
Valsartan—Gastrointestinal pain—Dapsone—malaria	0.000533	0.00236	CcSEcCtD
Valsartan—Anorexia—Quinidine barbiturate—malaria	0.000532	0.00235	CcSEcCtD
Valsartan—Anorexia—Pentoxifylline—malaria	0.000531	0.00235	CcSEcCtD
Valsartan—Headache—Sulfadiazine—malaria	0.000531	0.00235	CcSEcCtD
Valsartan—Hypotension—Quinidine barbiturate—malaria	0.000522	0.00231	CcSEcCtD
Valsartan—Hypotension—Pentoxifylline—malaria	0.000521	0.0023	CcSEcCtD
Valsartan—ALB—HDL-mediated lipid transport—SCARB1—malaria	0.000519	0.0346	CbGpPWpGaD
Valsartan—Gastrointestinal pain—Clindamycin—malaria	0.000516	0.00228	CcSEcCtD
Valsartan—Abdominal pain—Dapsone—malaria	0.000515	0.00228	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000509	0.00225	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000508	0.00225	CcSEcCtD
Valsartan—Gastrointestinal pain—Quinidine—malaria	0.000506	0.00224	CcSEcCtD
Valsartan—Gastrointestinal pain—Quinine—malaria	0.000506	0.00224	CcSEcCtD
Valsartan—Insomnia—Pentoxifylline—malaria	0.000504	0.00223	CcSEcCtD
Valsartan—Nausea—Sulfadiazine—malaria	0.000503	0.00222	CcSEcCtD
Valsartan—Urticaria—Clindamycin—malaria	0.000501	0.00222	CcSEcCtD
Valsartan—Abdominal pain—Clindamycin—malaria	0.000499	0.0022	CcSEcCtD
Valsartan—Dyspnoea—Quinidine barbiturate—malaria	0.000498	0.0022	CcSEcCtD
Valsartan—Dyspnoea—Pentoxifylline—malaria	0.000497	0.0022	CcSEcCtD
Valsartan—Somnolence—Quinidine barbiturate—malaria	0.000496	0.00219	CcSEcCtD
Valsartan—Somnolence—Pentoxifylline—malaria	0.000495	0.00219	CcSEcCtD
Valsartan—Urticaria—Quinidine—malaria	0.000491	0.00217	CcSEcCtD
Valsartan—Urticaria—Quinine—malaria	0.000491	0.00217	CcSEcCtD
Valsartan—Dyspepsia—Pentoxifylline—malaria	0.000491	0.00217	CcSEcCtD
Valsartan—Abdominal pain—Quinine—malaria	0.000489	0.00216	CcSEcCtD
Valsartan—Abdominal pain—Quinidine—malaria	0.000489	0.00216	CcSEcCtD
Valsartan—Decreased appetite—Quinidine barbiturate—malaria	0.000485	0.00215	CcSEcCtD
Valsartan—Decreased appetite—Pentoxifylline—malaria	0.000484	0.00214	CcSEcCtD
Valsartan—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000482	0.00213	CcSEcCtD
Valsartan—Constipation—Quinidine barbiturate—malaria	0.000477	0.00211	CcSEcCtD
Valsartan—Constipation—Pentoxifylline—malaria	0.000477	0.00211	CcSEcCtD
Valsartan—Hypersensitivity—Clindamycin—malaria	0.000465	0.00205	CcSEcCtD
Valsartan—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000457	0.00202	CcSEcCtD
Valsartan—Hypersensitivity—Quinine—malaria	0.000456	0.00202	CcSEcCtD
Valsartan—Hypersensitivity—Quinidine—malaria	0.000456	0.00202	CcSEcCtD
Valsartan—Gastrointestinal pain—Pentoxifylline—malaria	0.000456	0.00202	CcSEcCtD
Valsartan—Asthenia—Clindamycin—malaria	0.000452	0.002	CcSEcCtD
Valsartan—Pruritus—Clindamycin—malaria	0.000446	0.00197	CcSEcCtD
Valsartan—Asthenia—Quinine—malaria	0.000444	0.00196	CcSEcCtD
Valsartan—Asthenia—Quinidine—malaria	0.000444	0.00196	CcSEcCtD
Valsartan—Urticaria—Quinidine barbiturate—malaria	0.000444	0.00196	CcSEcCtD
Valsartan—Urticaria—Pentoxifylline—malaria	0.000443	0.00196	CcSEcCtD
Valsartan—Abdominal pain—Quinidine barbiturate—malaria	0.000441	0.00195	CcSEcCtD
Valsartan—Abdominal pain—Pentoxifylline—malaria	0.000441	0.00195	CcSEcCtD
Valsartan—Pruritus—Quinidine—malaria	0.000438	0.00194	CcSEcCtD
Valsartan—Pruritus—Quinine—malaria	0.000438	0.00194	CcSEcCtD
Valsartan—Diarrhoea—Clindamycin—malaria	0.000431	0.00191	CcSEcCtD
Valsartan—Diarrhoea—Quinidine—malaria	0.000423	0.00187	CcSEcCtD
Valsartan—Diarrhoea—Quinine—malaria	0.000423	0.00187	CcSEcCtD
Valsartan—ALB—Binding and Uptake of Ligands by Scavenger Receptors—HBB—malaria	0.000417	0.0278	CbGpPWpGaD
Valsartan—Dizziness—Clindamycin—malaria	0.000417	0.00184	CcSEcCtD
Valsartan—Vomiting—Dapsone—malaria	0.000415	0.00183	CcSEcCtD
Valsartan—Hypersensitivity—Quinidine barbiturate—malaria	0.000411	0.00182	CcSEcCtD
Valsartan—Hypersensitivity—Pentoxifylline—malaria	0.000411	0.00182	CcSEcCtD
Valsartan—Dizziness—Quinidine—malaria	0.000409	0.00181	CcSEcCtD
Valsartan—Dizziness—Quinine—malaria	0.000409	0.00181	CcSEcCtD
Valsartan—Headache—Dapsone—malaria	0.000408	0.00181	CcSEcCtD
Valsartan—Vomiting—Clindamycin—malaria	0.000401	0.00177	CcSEcCtD
Valsartan—Asthenia—Quinidine barbiturate—malaria	0.000401	0.00177	CcSEcCtD
Valsartan—Asthenia—Pentoxifylline—malaria	0.0004	0.00177	CcSEcCtD
Valsartan—Rash—Clindamycin—malaria	0.000398	0.00176	CcSEcCtD
Valsartan—Dermatitis—Clindamycin—malaria	0.000397	0.00176	CcSEcCtD
Valsartan—Headache—Clindamycin—malaria	0.000395	0.00175	CcSEcCtD
Valsartan—Pruritus—Quinidine barbiturate—malaria	0.000395	0.00175	CcSEcCtD
Valsartan—Pruritus—Pentoxifylline—malaria	0.000394	0.00174	CcSEcCtD
Valsartan—Vomiting—Quinidine—malaria	0.000393	0.00174	CcSEcCtD
Valsartan—Vomiting—Quinine—malaria	0.000393	0.00174	CcSEcCtD
Valsartan—Rash—Quinine—malaria	0.00039	0.00172	CcSEcCtD
Valsartan—Rash—Quinidine—malaria	0.00039	0.00172	CcSEcCtD
Valsartan—Dermatitis—Quinidine—malaria	0.00039	0.00172	CcSEcCtD
Valsartan—Dermatitis—Quinine—malaria	0.00039	0.00172	CcSEcCtD
Valsartan—Headache—Quinidine—malaria	0.000388	0.00171	CcSEcCtD
Valsartan—Headache—Quinine—malaria	0.000388	0.00171	CcSEcCtD
Valsartan—Nausea—Dapsone—malaria	0.000387	0.00171	CcSEcCtD
Valsartan—ALB—Binding and Uptake of Ligands by Scavenger Receptors—HP—malaria	0.000385	0.0257	CbGpPWpGaD
Valsartan—Diarrhoea—Quinidine barbiturate—malaria	0.000382	0.00169	CcSEcCtD
Valsartan—Diarrhoea—Pentoxifylline—malaria	0.000381	0.00169	CcSEcCtD
Valsartan—AGTR1—Allograft Rejection—IL12B—malaria	0.000377	0.0252	CbGpPWpGaD
Valsartan—Nausea—Clindamycin—malaria	0.000375	0.00166	CcSEcCtD
Valsartan—Dizziness—Quinidine barbiturate—malaria	0.000369	0.00163	CcSEcCtD
Valsartan—Dizziness—Pentoxifylline—malaria	0.000369	0.00163	CcSEcCtD
Valsartan—Nausea—Quinidine—malaria	0.000367	0.00162	CcSEcCtD
Valsartan—Nausea—Quinine—malaria	0.000367	0.00162	CcSEcCtD
Valsartan—Vomiting—Quinidine barbiturate—malaria	0.000355	0.00157	CcSEcCtD
Valsartan—Vomiting—Pentoxifylline—malaria	0.000354	0.00157	CcSEcCtD
Valsartan—Rash—Quinidine barbiturate—malaria	0.000352	0.00156	CcSEcCtD
Valsartan—Dermatitis—Quinidine barbiturate—malaria	0.000352	0.00156	CcSEcCtD
Valsartan—Rash—Pentoxifylline—malaria	0.000351	0.00155	CcSEcCtD
Valsartan—ALB—FOXA2 and FOXA3 transcription factor networks—PKLR—malaria	0.000351	0.0234	CbGpPWpGaD
Valsartan—Dermatitis—Pentoxifylline—malaria	0.000351	0.00155	CcSEcCtD
Valsartan—ALB—Vitamin B12 Metabolism—HBB—malaria	0.00035	0.0234	CbGpPWpGaD
Valsartan—Headache—Quinidine barbiturate—malaria	0.00035	0.00155	CcSEcCtD
Valsartan—Headache—Pentoxifylline—malaria	0.000349	0.00154	CcSEcCtD
Valsartan—AGTR1—Peptide ligand-binding receptors—ACKR1—malaria	0.000343	0.0229	CbGpPWpGaD
Valsartan—Nausea—Quinidine barbiturate—malaria	0.000332	0.00147	CcSEcCtD
Valsartan—Nausea—Pentoxifylline—malaria	0.000331	0.00146	CcSEcCtD
Valsartan—ALB—Lipoprotein metabolism—SCARB1—malaria	0.000298	0.0199	CbGpPWpGaD
Valsartan—SLCO1B3—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000292	0.0194	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—HBB—malaria	0.000285	0.019	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—CD40LG—malaria	0.000276	0.0184	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—IL10—malaria	0.000276	0.0184	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—IL4—malaria	0.000268	0.0179	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—HLA-B—malaria	0.000262	0.0175	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—FAS—malaria	0.000247	0.0165	CbGpPWpGaD
Valsartan—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SCARB1—malaria	0.000232	0.0155	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ACKR1—malaria	0.00023	0.0154	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—HBB—malaria	0.000226	0.0151	CbGpPWpGaD
Valsartan—ALB—Lipid and lipoprotein metabolism—SCARB1—malaria	0.000198	0.0132	CbGpPWpGaD
Valsartan—SLCO1B1—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000196	0.0131	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—SCARB1—malaria	0.000195	0.013	CbGpPWpGaD
Valsartan—CYP2C9—Arachidonic acid metabolism—HPGDS—malaria	0.000176	0.0118	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—ACKR1—malaria	0.000175	0.0117	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—IFNG—malaria	0.000162	0.0108	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—DHFR—malaria	0.00016	0.0107	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—SCARB1—malaria	0.000159	0.0106	CbGpPWpGaD
Valsartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—malaria	0.000151	0.0101	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—SLC4A1—malaria	0.000148	0.00988	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000146	0.00977	CbGpPWpGaD
Valsartan—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—malaria	0.000146	0.00971	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—IL1B—malaria	0.000145	0.00965	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—IL2—malaria	0.000144	0.00961	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—SCARB1—malaria	0.000126	0.0084	CbGpPWpGaD
Valsartan—ALB—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000112	0.00747	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—CRP—malaria	0.00011	0.00735	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—TNF—malaria	0.000105	0.007	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—IL4—malaria	0.000104	0.00692	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—ICAM1—malaria	0.000101	0.00676	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—SLC4A1—malaria	9.95e-05	0.00664	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—DECR1—malaria	9.84e-05	0.00657	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—ACKR1—malaria	9e-05	0.006	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—CRP—malaria	8.97e-05	0.00598	CbGpPWpGaD
Valsartan—ALB—Platelet degranulation—CD36—malaria	8.53e-05	0.00569	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—ICAM1—malaria	8.24e-05	0.0055	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—DHODH—malaria	8.16e-05	0.00544	CbGpPWpGaD
Valsartan—ALB—Response to elevated platelet cytosolic Ca2+—CD36—malaria	8.13e-05	0.00542	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—HPGDS—malaria	8.03e-05	0.00535	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—IFNG—malaria	7.71e-05	0.00514	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—SCARB1—malaria	7.37e-05	0.00492	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—CRP—malaria	7.12e-05	0.00475	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—SLC4A1—malaria	6.94e-05	0.00463	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—IL1B—malaria	6.88e-05	0.00459	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—HPGDS—malaria	6.57e-05	0.00438	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—ICAM1—malaria	6.55e-05	0.00437	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—DECR1—malaria	6.52e-05	0.00435	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—IFNG—malaria	6.27e-05	0.00418	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—HBB—malaria	5.9e-05	0.00394	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—SLC4A1—malaria	5.69e-05	0.00379	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—DECR1—malaria	5.62e-05	0.00375	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—IL1B—malaria	5.59e-05	0.00373	CbGpPWpGaD
Valsartan—ALB—Hemostasis—HBB—malaria	5.59e-05	0.00373	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—IL2—malaria	5.57e-05	0.00372	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—DHODH—malaria	5.48e-05	0.00366	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—HPGDS—malaria	5.39e-05	0.0036	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—ACKR1—malaria	5.32e-05	0.00355	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PKLR—malaria	5.26e-05	0.00351	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—TNF—malaria	4.99e-05	0.00333	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—IFNG—malaria	4.98e-05	0.00332	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—SCARB1—malaria	4.95e-05	0.0033	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—G6PD—malaria	4.69e-05	0.00313	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—SLC4A1—malaria	4.66e-05	0.00311	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—CD36—malaria	4.62e-05	0.00309	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—DECR1—malaria	4.6e-05	0.00307	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—IL1B—malaria	4.44e-05	0.00296	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—DECR1—malaria	4.38e-05	0.00292	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TLR9—malaria	4.28e-05	0.00286	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—TNF—malaria	4.06e-05	0.00271	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—IL6—malaria	4.03e-05	0.00269	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—HBB—malaria	3.96e-05	0.00264	CbGpPWpGaD
Valsartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—malaria	3.8e-05	0.00254	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—CD36—malaria	3.78e-05	0.00252	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—HPGDS—malaria	3.57e-05	0.00238	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PKLR—malaria	3.53e-05	0.00236	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—DHFR—malaria	3.32e-05	0.00221	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—SCARB1—malaria	3.28e-05	0.00219	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—IL6—malaria	3.28e-05	0.00219	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—TNF—malaria	3.23e-05	0.00215	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—G6PD—malaria	3.15e-05	0.0021	CbGpPWpGaD
Valsartan—ALB—Metabolism—DHODH—malaria	3.13e-05	0.00209	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—malaria	3.11e-05	0.00207	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—HPGDS—malaria	3.08e-05	0.00206	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.83e-05	0.00189	CbGpPWpGaD
Valsartan—ALB—Metabolism—SLC4A1—malaria	2.66e-05	0.00178	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—IL6—malaria	2.6e-05	0.00174	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—DHODH—malaria	2.56e-05	0.00171	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.52e-05	0.00168	CbGpPWpGaD
Valsartan—ALB—Metabolism—DECR1—malaria	2.5e-05	0.00167	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—HPGDS—malaria	2.4e-05	0.0016	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.32e-05	0.00154	CbGpPWpGaD
Valsartan—ALB—Metabolism—HBB—malaria	2.26e-05	0.00151	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—DHFR—malaria	2.23e-05	0.00149	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—SCARB1—malaria	2.21e-05	0.00147	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—SLC4A1—malaria	2.18e-05	0.00145	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—IL2—malaria	2.12e-05	0.00141	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—IL2—malaria	2.06e-05	0.00138	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CD36—malaria	2.06e-05	0.00137	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—DECR1—malaria	2.05e-05	0.00137	CbGpPWpGaD
Valsartan—ALB—Metabolism—PKLR—malaria	2.02e-05	0.00135	CbGpPWpGaD
Valsartan—ALB—Hemostasis—CD36—malaria	1.95e-05	0.0013	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—IL2—malaria	1.87e-05	0.00125	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—HBB—malaria	1.85e-05	0.00124	CbGpPWpGaD
Valsartan—ALB—Metabolism—G6PD—malaria	1.8e-05	0.0012	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—CD36—malaria	1.78e-05	0.00118	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—KDR—malaria	1.71e-05	0.00114	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PKLR—malaria	1.65e-05	0.0011	CbGpPWpGaD
Valsartan—ALB—Hemostasis—NOS2—malaria	1.6e-05	0.00107	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—G6PD—malaria	1.47e-05	0.000982	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—CD36—malaria	1.45e-05	0.000969	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CD36—malaria	1.38e-05	0.000923	CbGpPWpGaD
Valsartan—ALB—Metabolism—HPGDS—malaria	1.37e-05	0.000915	CbGpPWpGaD
Valsartan—ALB—Metabolism—DHFR—malaria	1.27e-05	0.000849	CbGpPWpGaD
Valsartan—ALB—Metabolism—SCARB1—malaria	1.26e-05	0.00084	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—HPGDS—malaria	1.12e-05	0.000749	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL2—malaria	1.11e-05	0.000738	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—IL6—malaria	1.1e-05	0.000734	CbGpPWpGaD
Valsartan—ALB—Hemostasis—IL2—malaria	1.09e-05	0.000729	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—DHFR—malaria	1.04e-05	0.000695	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—SCARB1—malaria	1.03e-05	0.000688	CbGpPWpGaD
Valsartan—ALB—Metabolism—CD36—malaria	7.91e-06	0.000527	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL6—malaria	6.5e-06	0.000434	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CD36—malaria	6.47e-06	0.000432	CbGpPWpGaD
